|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Marketable securities | |||||||||
| Accounts receivable, net | |||||||||
| Inventory | |||||||||
| Contract costs, current | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right-of-use assets | |||||||||
| Contract costs, long-term | |||||||||
| Other non-current assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders' equity | |||||||||
| Current liabilities | |||||||||
| Accounts payable | |||||||||
| Accrued liabilities | |||||||||
| Deferred revenue | |||||||||
| Contract liabilities, current | |||||||||
| Operating lease liability, current | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Long-term liabilities | |||||||||
| Notes payable, long-term | |||||||||
| Contract liabilities, long-term | |||||||||
| Other liabilities, long-term | |||||||||
| Operating lease liability, long-term | |||||||||
| Total long-term liabilities | |||||||||
| Total liabilities | |||||||||
| Redeemable convertible preferred stock, $0.001 par value; Authorized shares: none and 46,624,838 shares as of December 31, 2024 and December 31, 2023, respectively Issued and outstanding shares: none and 17,817,643 shares as of December 31, 2024 and December 31, 2023, respectively Aggregate liquidation preference of none and $152,590 as of December 31, 2024 and December 31, 2023, respectively | |||||||||
| Stockholders' equity | |||||||||
| Common stock, $0.001 par value; Authorized shares: 500,000,000 as of September 30, 2026 and December 31, 2025 Issued and outstanding shares: 38,820,703 and 37,485,124 as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...